DiaMedica Inc. Announces Results of Annual General and Special Meeting of Shareholders
November 28, 2016 19:00 ET
|
DiaMedica Inc.
MINNEAPOLIS, MINNESOTA--(Marketwired - Nov. 28, 2016) - DiaMedica Inc. (TSX VENTURE:DMA)(OTCQB:DMCAF) (the "Company"), today announced that at its Annual General and Special Meeting (the...
DiaMedica Establishes Neurological Scientific Advisory Board With Several Distinguished Experts
October 12, 2016 07:30 ET
|
DiaMedica Inc.
MINNEAPOLIS, MINNESOTA--(Marketwired - Oct. 12, 2016) - DiaMedica Inc. (the "Company") (TSX VENTURE:DMA)(OTCQB:DMCAF) today announced the establishment of a Scientific Advisory Board...
DiaMedica Announces First Patient Enrolled in Bridging Clinical Trial for DM199
October 05, 2016 08:00 ET
|
DiaMedica Inc.
MINNEAPOLIS, MINNESOTA--(Marketwired - Oct. 5, 2016) - DiaMedica Inc. (the "Company") (TSX VENTURE:DMA)(OTCQB:DMCAF) announced that the first patient has been dosed in the Phase Ib...
DiaMedica to Present at the 16th Annual Biotech in Europe Forum for Global Partnering and Investment Conference
September 26, 2016 08:00 ET
|
DiaMedica Inc.
MINNEAPOLIS, MINNESOTA--(Marketwired - Sept. 26, 2016) - DiaMedica Inc. (the "Company") (TSX VENTURE:DMA)(OTCQB:DMCAF), a biopharmaceutical company developing novel treatments for...
DiaMedica Announces Regulatory Clearance to Initiate Bridging Clinical Trial for DM199
September 12, 2016 08:00 ET
|
DiaMedica Inc.
MINNEAPOLIS, MINNESOTA--(Marketwired - Sept. 12, 2016) - DiaMedica Inc. (the "Company") (TSX VENTURE:DMA)(OTCQB:DMCAF) DiaMedica announced that it has received regulatory clearance in...
DiaMedica Completes Second Tranche of Non-Brokered Private Placement With Hermed Capital
September 08, 2016 13:51 ET
|
DiaMedica Inc.
WINNIPEG, MANITOBA and MINNEAPOLIS, MINNESOTA--(Marketwired - Sept. 8, 2016) - DiaMedica Inc. (the "Company") (TSX VENTURE:DMA)(OTCQB:DMCAF) is pleased to announce that it has closed the...
DiaMedica Completes First Tranche of Non-Brokered Private Placement with Hermed Capital
August 22, 2016 08:00 ET
|
DiaMedica Inc.
WINNIPEG, MANITOBA and MINNEAPOLIS, MINNESOTA--(Marketwired - Aug. 22, 2016) - DiaMedica Inc. (the "Company") (TSX VENTURE:DMA)(OTCQB:DMCAF) is pleased to announce that it has closed the...
DiaMedica Announces Strategic Investment by Hermed Capital Healthcare Fund
July 18, 2016 00:30 ET
|
DiaMedica Inc.
WINNIPEG, MANITOBA and MINNEAPOLIS, MINNESOTA--(Marketwired - July 17, 2016) - DiaMedica Inc. (the "Company") (TSX VENTURE:DMA)(OTCQB:DMCAF), today announced a strategic investment with...
DiaMedica Announces U.S. Composition of Matter Patent for DM199
June 14, 2016 08:00 ET
|
DiaMedica Inc.
MINNEAPOLIS, MINNESOTA--(Marketwired - June 14, 2016) - DiaMedica Inc. (the "Company") (TSX VENTURE:DMA)(OTCQB:DMCAF), today announced that the U.S. Patent and Trademark Office has issued...
DiaMedica Appoints Dr. Todd Verdoorn as Chief Scientific Officer
May 09, 2016 08:00 ET
|
DiaMedica Inc.
MINNEAPOLIS, MINNESOTA--(Marketwired - May 9, 2016) - DiaMedica Inc. (the "Company") (TSX VENTURE:DMA)(OTCQB:DMCAF) today announced the appointment of Dr. Todd Verdoorn as the Company's...